scispace - formally typeset
I

Isolde Sommer

Researcher at Danube University Krems

Publications -  33
Citations -  903

Isolde Sommer is an academic researcher from Danube University Krems. The author has contributed to research in topics: Medicine & Systematic review. The author has an hindex of 8, co-authored 18 publications receiving 489 citations.

Papers
More filters
Journal ArticleDOI

Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews.

TL;DR: Having low socioeconomic status (SES) and/or living in low and middle income countries (LMIC) increased the risk of developing cardiovascular diseases (CVD), lung and gastric cancer, type 2 diabetes, and chronic obstructive pulmonary disease (COPD) and low SES increased therisk of mortality from lung cancer, COPD, and reduced breast cancer survival in HIC.
Journal ArticleDOI

Prevalence of mental disorders in young refugees and asylum seekers in European Countries: a systematic review.

TL;DR: The prevalence estimates suggest that specialized mental health care services for the most vulnerable refugee and asylum-seeking populations are needed, and the highly heterogeneous evidence base could be improved by international, methodologically comparable studies with sufficiently large sample sizes drawn randomly among specific refugee populations.
Journal ArticleDOI

Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis.

TL;DR: Lifestyle intervention is an efficacious, safe, and cost-effective measure to reduce the risk of progression to type 2 diabetes in people diagnosed with prediabetes.
Journal ArticleDOI

Vitamin D deficiency as a risk factor for dementia: a systematic review and meta-analysis

TL;DR: The results of this systematic review show that low vitamin D levels might contribute to the development of dementia.
Journal ArticleDOI

[WHO Guideline for the Pharmacological Treatment of Hypertension in Adults].

TL;DR: The World Health Organization (WHO) guideline of 2021 as discussed by the authors provides the most up-to-date recommendations for the pharmacological treatment of adult patients with hypertension, which significantly increases the risk of heart, brain, kidney, and other diseases.